A new vaccine combination targeting two pathways of Epstein Barr virus (EBV) entry into human cells is progressing towards clinical development, taking us one step closer to understanding the complex association between MS and EBV.
World MS Day brings the global MS community together on May 30 to share stories, raise awareness and campaign with and on behalf of everyone affected by multiple sclerosis (MS).
A recent issue of the Australian Journal of General Practice has raised awareness about MS symptoms, recommendations for managing MS and understanding the lived experience of people with MS.
What’s one of the most powerful ways you can create a better future for people with multiple sclerosis (MS)? Leaving a gift in your Will.
Researchers have engaged with the Australian MS community to understand the needs of people with MS during times of crises.
A new paper from the International Progressive MS Alliance calls for a coordinated global approach to answering important questions on COVID-19 in progressive MS.
The PBAC has recommended the listing of Vumerity® for the treatment of RRMS and a new form of Copaxone® on the PBS.
A new report by MS Australia reveals that MS Nurse care improves health outcomes, but one-third of Australians living with MS do not have access to this life-changing support.
Australian researchers have developed an internet-delivered version of mindfulness-based stress reduction for people with MS.
